Measurement of Choroidal Thickness Following Caffeine Intake in Healthy Subjects. 2016

Hasan Altinkaynak, and Erdinç Ceylan, and Baki Kartal, and Sadullah Keleş, and Metin Ekinci, and Osman Okan Olcaysu
a Department of Ophthalmology , Ankara Ataturk Education and Research Hospital , Ankara , Turkey .

The aim of this study is to investigate the effect of 200 mg caffeine on subfoveal choroidal thickness (CT) in the macular area as measured by enhanced depth imaging optical coherence tomography (EDI-OCT) in healthy subjects. Fifty healthy individuals (study group) and 50 healthy individuals (control group) were enrolled in study. In the study group, participants received a 200 mg caffeine capsule and the control group consisted of subjects who received plasebo capsule. The subfoveal CT was measured by EDI-OCT before the caffeine intake and at 30 min, 1 h, 2 h, 3 h, 4 h and 6 h following caffeine intake. SFCT after caffeine intake was significantly decreased at 30 min, 1 h, 2 h, 3 h and 4 h compared to the baseline measurement, while the difference between baseline and 6 h was not statistically significant in the study group. There were no significant differences between the baseline and the other measurement times in the control group (p > 0.05). The thinning of CT begins about 30 min after the oral ingestion of 200 mg of caffeine and lasts for about four hours.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002110 Caffeine A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. 1,3,7-Trimethylxanthine,Caffedrine,Coffeinum N,Coffeinum Purrum,Dexitac,Durvitan,No Doz,Percoffedrinol N,Percutaféine,Quick-Pep,Vivarin,Quick Pep,QuickPep
D002829 Choroid The thin, highly vascular membrane covering most of the posterior of the eye between the RETINA and SCLERA. Choriocapillaris,Haller Layer,Haller's Layer,Sattler Layer,Sattler's Layer,Choroids
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

Hasan Altinkaynak, and Erdinç Ceylan, and Baki Kartal, and Sadullah Keleş, and Metin Ekinci, and Osman Okan Olcaysu
January 2015, Cutaneous and ocular toxicology,
Hasan Altinkaynak, and Erdinç Ceylan, and Baki Kartal, and Sadullah Keleş, and Metin Ekinci, and Osman Okan Olcaysu
January 2018, Journal of ophthalmic & vision research,
Hasan Altinkaynak, and Erdinç Ceylan, and Baki Kartal, and Sadullah Keleş, and Metin Ekinci, and Osman Okan Olcaysu
January 2014, Turkish journal of medical sciences,
Hasan Altinkaynak, and Erdinç Ceylan, and Baki Kartal, and Sadullah Keleş, and Metin Ekinci, and Osman Okan Olcaysu
December 2011, Investigative ophthalmology & visual science,
Hasan Altinkaynak, and Erdinç Ceylan, and Baki Kartal, and Sadullah Keleş, and Metin Ekinci, and Osman Okan Olcaysu
April 2010, Investigative ophthalmology & visual science,
Hasan Altinkaynak, and Erdinç Ceylan, and Baki Kartal, and Sadullah Keleş, and Metin Ekinci, and Osman Okan Olcaysu
June 2013, BMC ophthalmology,
Hasan Altinkaynak, and Erdinç Ceylan, and Baki Kartal, and Sadullah Keleş, and Metin Ekinci, and Osman Okan Olcaysu
January 2015, Clinical ophthalmology (Auckland, N.Z.),
Hasan Altinkaynak, and Erdinç Ceylan, and Baki Kartal, and Sadullah Keleş, and Metin Ekinci, and Osman Okan Olcaysu
November 2014, Indian journal of ophthalmology,
Hasan Altinkaynak, and Erdinç Ceylan, and Baki Kartal, and Sadullah Keleş, and Metin Ekinci, and Osman Okan Olcaysu
June 2012, American journal of ophthalmology,
Hasan Altinkaynak, and Erdinç Ceylan, and Baki Kartal, and Sadullah Keleş, and Metin Ekinci, and Osman Okan Olcaysu
January 2014, European journal of ophthalmology,
Copied contents to your clipboard!